Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Micksche

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
British Journal of Cancer|March 8, 2007
Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastomaS Spiegl-Kreinecker, C Pirker, C Marosi, et al.
Digestive Diseases and Sciences|April 1, 1995
Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's diseaseC Gasché, W Reinisch, H Vogelsang, et al.
Urology|March 15, 2001
Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargementG Schatzl, A Gsur, G Bernhofer, et al.
Gynecologic Oncology|December 1, 1989
Use of CA 125 monoclonal antibody to monitor patients with ovarian cancerS Kudlacek, K Schieder, H Kölbl, et al.
Onkologie|February 1, 1982
[Results of a comparative therapy study for inoperable lung cancer]O Kokron, G Alth, C Cerni, et al.
Journal of the National Cancer Institute|January 4, 1989
Expression and release of interleukin-1 by different human melanoma cell linesA Köck, T Schwarz, A Urbanski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
IFN-beta 2/IL-6 augments the activity of human natural killer cellsT A Luger, J Krutmann, R Kirnbauer, et al.
Cancer Chemotherapy Reports. Part 3|March 1, 1973
Aspects of the immunologic treatment of lung cancerG Alth, H Denck, M Fischer, et al.
Klinische Wochenschrift|July 15, 1987
[Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia]J D Schwarzmeier, L Wagner, F Prischl, et al.
Cancer Chemotherapy Reports. Part 3|March 1, 1973
Immunologic status before and during immunotherapy (immuneprofile)G Alth, H Denck, M Fischer, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|March 8, 2007
Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastomaS Spiegl-Kreinecker, C Pirker, C Marosi, et al.
Digestive Diseases and Sciences|April 1, 1995
Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's diseaseC Gasché, W Reinisch, H Vogelsang, et al.
Urology|March 15, 2001
Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargementG Schatzl, A Gsur, G Bernhofer, et al.
Gynecologic Oncology|December 1, 1989
Use of CA 125 monoclonal antibody to monitor patients with ovarian cancerS Kudlacek, K Schieder, H Kölbl, et al.
Onkologie|February 1, 1982
[Results of a comparative therapy study for inoperable lung cancer]O Kokron, G Alth, C Cerni, et al.
Journal of the National Cancer Institute|January 4, 1989
Expression and release of interleukin-1 by different human melanoma cell linesA Köck, T Schwarz, A Urbanski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
IFN-beta 2/IL-6 augments the activity of human natural killer cellsT A Luger, J Krutmann, R Kirnbauer, et al.
Cancer Chemotherapy Reports. Part 3|March 1, 1973
Aspects of the immunologic treatment of lung cancerG Alth, H Denck, M Fischer, et al.
Klinische Wochenschrift|July 15, 1987
[Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia]J D Schwarzmeier, L Wagner, F Prischl, et al.
Cancer Chemotherapy Reports. Part 3|March 1, 1973
Immunologic status before and during immunotherapy (immuneprofile)G Alth, H Denck, M Fischer, et al.
Pageof 16